FDA NDC Directory · JSON-LD · Markdown

NEOSTIGMINE METHYLSULFATE

NDC 42023-188 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerPar Health USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA208405
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNEOSTIGMINE METHYLSULFATE (.5 mg/mL)
Marketing started20170426
Package count1

External sources

Source: openFDA. Public-domain (CC0).